Pacer Advisors Inc. boosted its holdings in Catalent, Inc. (NYSE:CTLT) by 18.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,070 shares of the company’s stock after buying an additional 2,342 shares during the period. Pacer Advisors Inc.’s holdings in Catalent were worth $602,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Acrospire Investment Management LLC grew its position in shares of Catalent by 72.2% during the 2nd quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock valued at $109,000 after purchasing an additional 1,300 shares in the last quarter. Quantbot Technologies LP grew its position in shares of Catalent by 110.7% during the 2nd quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock valued at $120,000 after purchasing an additional 1,804 shares in the last quarter. Fortaleza Asset Management Inc. purchased a new position in shares of Catalent during the 3rd quarter valued at $164,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Catalent by 12.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,043 shares of the company’s stock valued at $177,000 after purchasing an additional 559 shares in the last quarter. Finally, Advisor Group Inc. grew its position in shares of Catalent by 1.3% during the 2nd quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock valued at $180,000 after purchasing an additional 65 shares in the last quarter. Institutional investors and hedge funds own 99.44% of the company’s stock.

In other Catalent news, Director Uwe Roehrhoff purchased 7,500 shares of the stock in a transaction on Tuesday, November 21st. The stock was acquired at an average cost of $39.22 per share, with a total value of $294,150.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.70% of the company’s stock.

CTLT has been the subject of a number of research analyst reports. BidaskClub downgraded shares of Catalent from a “buy” rating to a “hold” rating in a report on Tuesday, November 14th. Zacks Investment Research raised shares of Catalent from a “hold” rating to a “buy” rating and set a $39.00 price objective for the company in a report on Tuesday, August 22nd. William Blair reaffirmed an “ourperform” rating on shares of Catalent in a report on Tuesday, August 29th. ValuEngine raised shares of Catalent from a “hold” rating to a “buy” rating in a report on Thursday, September 7th. Finally, Bank of America reaffirmed a “buy” rating and set a $40.00 price objective (up from $38.00) on shares of Catalent in a report on Tuesday, August 29th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Catalent presently has a consensus rating of “Buy” and an average target price of $42.11.

Catalent, Inc. (CTLT) traded down $0.99 during trading on Friday, reaching $38.80. 612,803 shares of the company’s stock traded hands, compared to its average volume of 913,431. The company has a debt-to-equity ratio of 2.01, a current ratio of 2.91 and a quick ratio of 2.49. The company has a market capitalization of $5,150.00, a P/E ratio of 28.26, a PEG ratio of 2.60 and a beta of 1.49. Catalent, Inc. has a 1-year low of $23.03 and a 1-year high of $43.39.

Catalent (NYSE:CTLT) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. The business had revenue of $543.90 million during the quarter, compared to the consensus estimate of $490.75 million. Catalent had a net margin of 5.01% and a return on equity of 23.97%. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.16 earnings per share. analysts predict that Catalent, Inc. will post 1.46 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://www.dailypolitical.com/2017/12/01/pacer-advisors-inc-acquires-2342-shares-of-catalent-inc-ctlt.html.

About Catalent

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Institutional Ownership by Quarter for Catalent (NYSE:CTLT)

Receive News & Ratings for Catalent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.